To further confirm the role of XBP1s in tumor response to CDK4/6 inhibitors plus endocrine therapy, we generated cell‐derived xenograft models using XBP1s‐overexpressing and control MCF7 cells. This evidence concerns the gene CDK4 and neoplasm.